| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Statistical methods for assessing agreement between two methods of clinical measurement.
|
1986
|
211.50
|
|
2
|
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
|
1998
|
95.79
|
|
3
|
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
2012
|
56.72
|
|
4
|
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
2012
|
50.94
|
|
5
|
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
|
2002
|
44.28
|
|
6
|
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
|
1997
|
44.03
|
|
7
|
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
|
2005
|
42.90
|
|
8
|
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
|
2004
|
42.12
|
|
9
|
Health professionals for a new century: transforming education to strengthen health systems in an interdependent world.
|
2010
|
42.10
|
|
10
|
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
2012
|
41.47
|
|
11
|
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
|
1994
|
40.72
|
|
12
|
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
|
2002
|
40.37
|
|
13
|
Assessment of coma and impaired consciousness. A practical scale.
|
1974
|
39.76
|
|
14
|
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.
|
2004
|
39.54
|
|
15
|
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
|
2007
|
38.98
|
|
16
|
Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.
|
1993
|
38.49
|
|
17
|
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.
|
2006
|
37.83
|
|
18
|
The inverse care law.
|
1971
|
37.77
|
|
19
|
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.
|
1999
|
37.76
|
|
20
|
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
|
2007
|
37.69
|
|
21
|
Retracted
Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.
|
1998
|
36.93
|
|
22
|
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.
|
2008
|
36.01
|
|
23
|
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
|
2001
|
35.17
|
|
24
|
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
|
1998
|
34.34
|
|
25
|
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5.
|
2010
|
33.69
|
|
26
|
Global burden of hypertension: analysis of worldwide data.
|
2005
|
32.76
|
|
27
|
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.
|
1984
|
32.58
|
|
28
|
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
|
2005
|
32.41
|
|
29
|
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
|
2006
|
31.79
|
|
30
|
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
|
2001
|
31.74
|
|
31
|
Closing the gap in a generation: health equity through action on the social determinants of health.
|
2008
|
31.30
|
|
32
|
How many child deaths can we prevent this year?
|
2003
|
30.39
|
|
33
|
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
|
2005
|
29.45
|
|
34
|
Mortality by cause for eight regions of the world: Global Burden of Disease Study.
|
1997
|
29.18
|
|
35
|
4 million neonatal deaths: when? Where? Why?
|
2005
|
28.92
|
|
36
|
Where and why are 10 million children dying every year?
|
2003
|
28.59
|
|
37
|
From best evidence to best practice: effective implementation of change in patients' care.
|
2003
|
27.61
|
|
38
|
Human resources for health: overcoming the crisis.
|
2004
|
27.45
|
|
39
|
A rapid banding technique for human chromosomes.
|
1971
|
27.45
|
|
40
|
Inflammation and cancer: back to Virchow?
|
2001
|
27.40
|
|
41
|
Assessment of outcome after severe brain damage.
|
1975
|
27.39
|
|
42
|
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
2012
|
26.95
|
|
43
|
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
|
2014
|
26.76
|
|
44
|
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
|
1998
|
26.64
|
|
45
|
Global, regional, and national causes of child mortality in 2008: a systematic analysis.
|
2010
|
26.48
|
|
46
|
Maternal and child undernutrition: global and regional exposures and health consequences.
|
2008
|
26.44
|
|
47
|
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.
|
2009
|
26.09
|
|
48
|
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.
|
2012
|
25.96
|
|
49
|
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.
|
1997
|
25.40
|
|
50
|
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
|
2010
|
25.32
|